格隆汇12月10日丨嘉事堂(002462.SZ)在投资者互动平台表示，公司目前有胸腺肽、免疫球蛋白等相关 药品的销售业务。 ...

| 1.出现会议的股东和代理人人数 | 778 | | --- | --- | | 2.出席会议的股东学的有表决就的股份总数段》 | 464,351,992 | | CHANTER PRODUCTION CONSULTION CONSTITUTION OF CONSTITUTION OF CONSTITUTION OF COLORIO COLLEGIONAL CONTENTION OF COLLECTIONS OF COLLECTIONS OF COLLECTIONS OF CONSULTION OF CON | | | 3.出现会议的股东师持有要求权益好看与公司有表决权股份应用的比例(%) | 618091 | | 1X 00 5 3 80 | P-049-12 | 10 | | | --- | --- | --- | --- | | | 465,756,174 | 99.872 | | | 1 200 | | 球盘名 | | | | 1977 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 赢钱 | 世朗(s) | -10-12- ...

关于"*ST苏吴""合富中国" "海王生物"交易风险提示的公告 尊敬的投资者: "*ST苏吴"(600200)近期发布收到股票终 止上市决定的公告及公司股票进入退市整理期交易的公 告。上述公告明确称,公司于2025年12月1日收到上海 证券交易所出具的《关于江苏吴中医药发展股份有限公 司股票终止上市的决定》,上海证券交易所决定终止公 司股票上市。公司股票进入退市整理期的起始日为2025 年12月9日,退市整理期为15个交易日,退市整理期届 满后5个交易目内,上海证券交易所将对公司股票予以 摘牌,公司股票终止上市,请广大投资者理性投资并注 意投资风险。 上交所将对上述股票上的异常交易行为进行从严认 定,并视情况从重采取列为重点监控账户、暂停投资者 账户交易、限制投资者账户交易等自律管理措施。 二、"合富中国"（603122）股价近期波动较大, 已触及特别严重情形。公司发布公告称,公司主营业务 未发生重大变化,且处于亏损状态,公司股价短期内连 续上涨,已严重显著偏离公司基本面,存在市场情绪过 热、非理性炒作风险,请投资者理性决策,审慎投资。 上交所将对上述股票上的异常交易行为进行进一步 从严认定,并视情况从重采取 ...

截至发稿，国药股份市值为218亿元。 （记者 曾健辉） 2024年1至12月份，国药股份的营业收入构成为：医药商业占比104.55%，医药工业占比0.93%，仓储物 流占比0.78%，其他业务占比0.19%，内部抵销占比-6.45%。 每经AI快讯，国药股份（SH 600511，收盘价：28.88元）12月9日晚间发布公告称，公司第八届第三十 三次董事会会议于2025年12月9日以现场结合通讯表决方式召开。会议审议了《国药股份关于调整第八 届董事会专门委员会委员的议案》等文件。 每经头条（nbdtoutiao）——处方药变"瘾品"：国内首次报告普瑞巴林滥用致成瘾病例，网络平台暴 露"无病历可购药"漏洞，列管与否尚需科学考量 ...

证券之星消息，12月9日医药商业板块较上一交易日下跌1.88%，瑞康医药领跌。当日上证指数报收于 3909.52，下跌0.37%。深证成指报收于13277.36，下跌0.39%。医药商业板块个股涨跌见下表： 从资金流向上来看，当日医药商业板块主力资金净流出10.12亿元，游资资金净流出4503.85万元，散户 资金净流入10.57亿元。医药商业板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 ...

Market Overview - On December 9, A-shares showed mixed performance with the Shanghai Composite Index down by 0.37% and the Shenzhen Component Index down by 0.39%, while the ChiNext Index rose by 0.61% [1] - The total market turnover was 1.92 trillion yuan, a decrease of 134 billion yuan compared to the previous trading day, with over 4,000 stocks declining [1] Sector Performance - The Hainan sector experienced significant declines, with New Dazhou A hitting the daily limit down, and other stocks like Kangzhi Pharmaceutical and Hainan Haiyao dropping over 7% [4][5] - The pharmaceutical retail sector also saw a collective downturn, with stocks like Ruikang Pharmaceutical and Haiwang Biological hitting the daily limit down, and others like People's Tongtai and Hefei China dropping over 6% [5][6] - Precious metals sector weakened, with Zhongjin Gold leading the decline, down over 4%, and other stocks like Hunan Silver and Chifeng Gold also falling [7][8] - The coal sector showed negative performance, with New Dazhou A hitting the limit down and other companies like Antai Group and Dayou Energy dropping over 4% [9] - The CPO concept stocks surged, with Dekeli and Shaanxi Huada hitting the daily limit up, and other stocks like Qianzhao Optoelectronics and Tengjing Technology rising over 10% [10] Notable Stocks - In the Hainan sector, New Dazhou A closed at 6.31 yuan, down 9.99%, while Kangzhi Pharmaceutical closed at 10.80 yuan, down 7.85% [5][6] - In the precious metals sector, Zhongjin Gold closed at 21.31 yuan, down 4.65%, while Hunan Silver closed at 6.25 yuan, down 3.10% [7][8] - In the coal sector, New Dazhou A closed at 6.31 yuan, down 9.99%, and Antai Group closed at 4.81 yuan, down 5.31% [9] - In the retail sector, Central Mall and Maoye Commercial both hit the daily limit up, with Central Mall closing at 4.06 yuan, up 10.03% [12] Industry Insights - The global optical module industry is accelerating upgrades to 800G/1.6T driven by AI computing demand, with optical isolators becoming a critical component due to upstream material shortages [10] - The solar sector saw a surge in stocks like Aerospace Electromechanical, which closed at 14.83 yuan, up 10.01%, and Dike shares, which rose over 8% [17][18] - The film sector showed some gains, with Bona Film Group hitting the daily limit up, closing at 10.65 yuan, up 10.02% [15][16]

Market Performance - The A-share market experienced fluctuations, with the Shanghai Composite Index closing down 0.37% at 3909.52 points, and the Shenzhen Component Index down 0.39% at 13277.36 points, while the ChiNext Index rose 0.61% to 3209.60 points. The total trading volume in the Shanghai and Shenzhen markets reached 1.9 trillion yuan, with over 4000 stocks declining [1]. Sector Highlights - The computing power hardware sector saw significant gains, with Dekoli hitting the daily limit, and companies like Fuzhijing Technology and Tianfu Communication reaching historical highs. Shenghong Technology rose over 10% [1]. - The retail sector showed strong performance, with Yonghui Supermarket, Maoye Commercial, and Central Plaza hitting the daily limit. The CPO concept also gained traction, with Dekoli reaching the daily limit again [2]. - The Fujian sector was notably active, with Anji Food achieving six consecutive daily limits, and other companies like Shuhua Sports and Dongbai Group also performing well [3]. Institutional Insights - GF Securities indicated that large-cap stocks are expected to outperform small-cap stocks in December, with a focus on dividend stocks. The firm noted that the market's performance in December historically shows a 57% probability of gains, and emphasized the importance of upcoming key meetings for policy direction [4]. - Open Source Securities suggested that the recent market pullback may be concluding, recommending early positioning for a potential spring rally driven by both technology and cyclical sectors [6]. - Dongfang Securities highlighted that while the market is currently in a short-term rebound, the medium-term trend remains one of consolidation, with a focus on TMT, upstream resources, and AI sectors [7].

Market Performance - The three major A-share indices showed mixed results, with the Shanghai Composite Index down 0.37% to 3909 points, the Shenzhen Component Index down 0.39%, and the ChiNext Index up 0.61% [1] - The total market turnover was 1.92 trillion yuan, a decrease of 134 billion yuan compared to the previous trading day, with over 4000 stocks declining [1] Sector Performance - The Hainan sector declined, with Xin Dazhou A hitting the daily limit down [1] - The pharmaceutical retail sector fell sharply, with Ruikang Pharmaceutical and Haiwang Biological both hitting the daily limit down [1] - The precious metals sector weakened, led by Zhongjin Gold [1] - The phosphate chemical sector experienced fluctuations, with Luoping Zinc & Electricity down nearly 6% [1] - Sectors such as coal, steel, automotive dismantling, and lithium mining saw significant declines [1] Gainers - The nano-silver sector rose, with Yintang Zhikong increasing by over 11% [1] - The CPO concept was active, with Dekeli hitting the daily limit up [1] - The commercial retail sector saw gains, with stocks like Yonghui Supermarket and Central Plaza hitting the daily limit up [1] - Sectors such as lidar, lottery concepts, and dairy also showed strong performance [1] Sector Rankings - The electronics components sector led with a gain of 2.12% [2] - The communication equipment sector followed with a gain of 0.95% [2] - The office supplies and motorcycle sectors also saw positive net capital inflows [2]

A股市场板块涨跌幅排行 中国经济网北京12月9日讯 今日早盘两市震荡，截至午间收盘，上证指数报3918.83点，跌幅0.13%；深证成指报13341.62点，涨幅0.09%；创业板指报 3224.38点，涨幅1.07%。 | 序号 | 板块 | 涨跌幅(%)▼ | | 总成交量 (万手) ▼ 总成交额 (亿元) ▼ | 浄流入（亿元） ▼ | 上涨家数 | 下跌家 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 元件 | 2.48 | 1355.05 | 580.34 | 77.90 | ਦੇਤੋ | 6 | | 2 | 通信服务 | 1.34 | 880.17 | 154.47 | 3.03 | 24 | 19 | | ന | 零售 | 1.30 | 2957.46 | 185.43 | -4.58 | 46 | 23 | | ব | 军工电子 | 1.04 | 1953.50 | 352.79 | -18.71 | 40 | 22 | | 5 | 其他电源设备 | 1.02 | 473.20 | 141.01 | 0.13 | 20 | ...

"1、不会越权干预公司经营管理活动，不会侵占公司利益； 2、自本承诺出具日至公司本次向特定对象发行股票实施完毕前，若中国证监会及上海证券交易所做出 关于填补回报措施及其承诺的其他新的监管规定的，且上述承诺不能满足中国证监会及上海证券交易所 该等规定时，本单位承诺届时将按照中国证监会及上海证券交易所的最新规定出具补充承诺； 3、切实履行公司制定的有关填补回报措施以及本单位对此作出的任何有关填补回报措施的承诺，若本 单位违反该等承诺并给公司或者投资者造成损失的，本单位愿意依法承担对公司或者投资者的补偿责 任。" 登录新浪财经APP 搜索【信披】查看更多考评等级 特此公告。 河南太龙药业股份有限公司董事会 2025年12月9日 证券代码：600222 证券简称：太龙药业 公告编号：2025-064 河南太龙药业股份有限公司 关于股东签署《股份转让协议》《一致行动协议》 及公司签署《附条件生效的股份认购协议》 暨控股股东、实际控制人拟发生变更的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 控股股东或实 ...